Dr. Shah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1000 Wall St
Ann Arbor, MI 48105Phone+1 734-764-4190Fax+1 734-647-8052
Summary
- Dr. Anjali Shah is a retina specialist who sees patients at the University of Michigan Kellogg Eye Center’s offices in Ann Arbor and Brighton. Her clinical specialties include non-surgical management of diseases of the retina and vitreous, including diabetic retinopathy, age-related macular degeneration, retinal vascular diseases, uveitis, choroidal melanoma, and retinal tears and detachment.
Dr. Shah’s research interests include improving patient outcomes with novel testing and therapeutic approaches for age-related macular degeneration and diabetic retinopathy. To make an appointment, please call Kellogg’s Retina and Uveitis Clinic at 734-763-5874. To refer a patient, please visit www.kellogg.umich.edu/refer.
Education & Training
- St Joseph Mercy Ann ArborInternship, Transitional Year, 2006 - 2007
- University of Michigan Medical SchoolClass of 2006
- Regents of The University of Michigan - Regional Alliance for HEAB.A., Economics, University Honors, 1998 - 2001
Certifications & Licensure
- MI State Medical License 2006 - 2026
- MA State Medical License 2010 - 2014
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012
- Intern of the Month St. Joseph Mercy Hospital, 2006
- Join now to see all
Publications & Presentations
PubMed
- 30 citationsDiabetic retinopathy: research to clinical practice.Anjali R. Shah, Thomas W. Gardner
Clinical Diabetes and Endocrinology. 2017-10-19 - 36 citationsPredictors of Response to Intravitreal Anti–Vascular Endothelial Growth Factor Treatment of Age-Related Macular DegenerationAnjali R. Shah, Steven L. Williams, Caroline R. Baumal, Bernard Rosner, Jay S. Duker
American Journal of Ophthalmology. 2016-03-01 - 13 citationsBlood Pressure Is Associated with Receiving Intravitreal Anti-Vascular Endothelial Growth Factor Treatment in Patients with Diabetes.Anjali R. Shah, Adam N. Van Horn, Lilia Verchinina, Michele Wichorek, Lydia Su
Ophthalmology. Retina. 2019-05-01
Lectures
- Behcet's Disease Case - Grand Rounds2011
- Medical Retina Conferences2011
- Open Globes and Other On-Call Emergencies7/2009
- Join now to see all
Press Mentions
- Ophthalmologists Link Immunotherapy Cancer Drugs to Uveal EffusionMay 1st, 2018
- Researchers Seek Path to Prevent Macular DegenerationDecember 10th, 2015
- High Blood Pressure May Lead to More Diabetic Eye InjectionsMay 10th, 2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: